SAN DIEGO — Boston Pharmaceuticals’ once-monthly efimosfermin alfa (formerly BOS-580) prescribed for metabolic dysfunction–associated steatohepatitis (MASH) with F2 and F3 fibrosis significantly improved MASH resolution and fibrosis after 24 weeks, according to results of a phase 2 trial presented at Digestive Disease Week (DDW) 2025. An analogue of the fibroblastContinue Reading
A novel investigational endoscopic procedure targeting the duodenum appears beneficial in improving glycemic parameters in people with type 2 diabetes (T2D). In a new dose-finding study, the re-cellularization via electroporation therapy (ReCET, Endogenex) improved insulin sensitivity, beta-cell function, and other glycemic parameters at 12 and 48 weeks in 51 individualsContinue Reading
Please complete security verification This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our supportContinue Reading
Washington, D.C., May 8, 2025) – U.S. Secretary of Agriculture Brooke Rollins will visit the United Kingdom May 12-14. This comes after President Donald J. Trump announced today, on the 80th anniversary of Victory in Europe, a new trade agreement in principle that will lower tariffs…Read MoreContinue Reading
Please complete security verification This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our supportContinue Reading
TOPLINE: Levels of 25-hydroxy (OH) vitamin D below 37 nmol/L during childhood were significantly associated with an increased risk for adult-onset atherosclerotic cardiovascular disease (CVD) events. METHODOLOGY: Researchers analysed data from a prospective study in Finland to evaluate the relationship between low levels of vitamin D during childhood and adult-onsetContinue Reading
If you’re a regular coffee drinker, chances are you’re well aware that your stomach isn’t always on board with the buzzy beverage. In fact, more than 20% are estimated to experience digestive symptoms of some sort, according to a 2003 study published in the journal Digestive Diseases and Sciences. WhatContinue Reading
Please complete security verification This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our supportContinue Reading
TOPLINE: Transmural healing, assessed using faecal calprotectin (FC) levels and intestinal ultrasonography (IUS), was associated with a reduced risk for bowel damage progression and thereby improved long-term outcomes in Crohn’s disease (CD). METHODOLOGY: Researchers conducted a prospective cross-sectional observational study at an inflammatory bowel disease referral centre (February to AprilContinue Reading
TOPLINE: Implementing physician-led medication reviews through interdisciplinary dialogue could reduce the number of prescribed drugs and potentially inappropriate prescriptions in patients with diabetes and severe mental disorders, without worsening psychiatric symptoms. METHODOLOGY: Patients with both diabetes and severe mental disorders may experience inappropriate polypharmacy, which increases their risk for sideContinue Reading
Skip to content